Metraipolis › archive › dc_16e85286ef8b
The health and economic burden of respiratory syncytial virus associated hospitalizations in adults — Europe PMC PMID:32525898
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32525898
- DOI
- 10.1371/journal.pone.0234235
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T12:50:44.136Z
- SHA-256 of the archived text
64a04235995f3e10ea8fe42290fedf7135148542fe8f53f33b8353b3f7e298ba- Stable URL of this page
https://metraipolis.com/documento/dc_16e85286ef8b
How to cite
The health and economic burden of respiratory syncytial virus associated hospitalizations in adults — Europe PMC PMID:32525898 — Europe PMC (en), https://europepmc.org/article/MED/32525898 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_16e85286ef8b (Metraipolis archive dc_16e85286ef8b, sha256 64a04235995f3e10ea8fe42290fedf7135148542fe8f53f33b8353b3f7e298ba)
BibTeX
@misc{dc16e85286ef8b,
title = {The health and economic burden of respiratory syncytial virus associated hospitalizations in adults — Europe PMC PMID:32525898},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32525898},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_16e85286ef8b; sha256 64a04235995f3e10ea8fe42290fedf7135148542fe8f53f33b8353b3f7e298ba},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32525898. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Respiratory syncytial virus (RSV) is increasingly recognized as an important cause of illness in adults; however, data on RSV disease and economic burden in this age group remain limited. We aimed to provide comprehensive estimates of RSV disease burden among adults aged ≥18 years. Methods: During 2012-2015, population-based, active surveillance of acute respiratory infection (ARI) hospitalizations enabled estimation of the seasonal incidence of RSV hospitalizations and direct health costs in adults aged ≥18 years in Auckland, New Zealand. Results: Of 4,600 ARI hospitalizations tested for RSV, 348 (7.6%) were RSV positive. The median (interquartile range) length of hospital stay for RSV positive patients was 4 (2-6) days. The seasonal incidence rate (IR) of RSV hospitalizations, corrected for non-testing, was 23.6 (95% confidence intervals [CI] 21.0-26.1) per 100,000 adults aged ≥18 years. Hospitalization risk increased with age with the highest incidence among adults aged ≥80 years (IR 190.8 per 100,000, 95% CI 137.6-244.0). Being of Māori or Pacific ethnicity or living in a neighborhood with low socioeconomic status (SES) were independently associated with increased RSV hospitalization rates. We estimate RSV-associated hospitalizations among adults aged ≥18 years to cost on average NZD $4,758 per event. Conclusions: RSV infection is associated with considerable disease and economic cost in adults. RSV disproportionally affects adult sub-groups defined by age, ethnicity, and neighborhood SES. An effective RSV vaccine or RSV treatment may offer benefits for older adults. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-06-11). Identificativi: PMID 32525898 · PMCID PMC7289360 · DOI 10.1371/journal.pone.0234235. Descrittori MeSH principali: Cost of Illness. Pagina: https://europepmc.org/article/MED/32525898 — https://doi.org/10.1371/journal.pone.0234235. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T12:46:55.967Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.